Parabilis Medicines, Inc. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Parabilis Medicines, Inc. (PBLS) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$2.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-13
- 2026-06-30: Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month -$2.66M.
- 2025-06-30: Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month $4.08M.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month |
|---|---|
| 2026-06-30 | -$2.66M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $4.08M 10-Q · filed 2026-08-13 |